{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:30:15Z","timestamp":1761539415234},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2008,12,23]],"date-time":"2008-12-23T00:00:00Z","timestamp":1229990400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s00432-008-0526-8","type":"journal-article","created":{"date-parts":[[2008,12,22]],"date-time":"2008-12-22T07:55:04Z","timestamp":1229932504000},"page":"909-917","source":"Crossref","is-referenced-by-count":18,"title":["Integrin \u03b23 down-regulates invasive features of ovarian cancer cells in SKOV3 cell subclones"],"prefix":"10.1007","volume":"135","author":[{"given":"Jie","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaoran","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maosun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,12,23]]},"reference":[{"key":"526_CR1","first-page":"3239","volume":"47","author":"A Albini","year":"1987","unstructured":"Albini A, Iwamoto Y, Kleinman HK et al (1987) Arapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47:3239\u20133245","journal-title":"Cancer Res"},{"key":"526_CR2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1034\/j.1600-065X.2002.18612.x","volume":"186","author":"MA Arnaout","year":"2002","unstructured":"Arnaout MA (2002) Integrin structure: new twists and turns in dynamic cell adhesion. Immunol Rev 186:125\u2013140. doi: 10.1034\/j.1600-065X.2002.18612.x","journal-title":"Immunol Rev"},{"key":"526_CR3","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1002\/ijc.22879","volume":"121","author":"K Bauer","year":"2007","unstructured":"Bauer K, Mierke C, Behrens J (2007) Expression profiling reveals genes associated with transendothelial migration of tumor cells: a functional role for alphavbeta3 integrin. Int J Cancer 121:1910\u20131918. doi: 10.1002\/ijc.22879","journal-title":"Int J Cancer"},{"key":"526_CR4","first-page":"325","volume":"30","author":"O Baum","year":"2007","unstructured":"Baum O, Hlushchuk R, Forster A, Greiner R, Cl\u00e9Zardin P, Zhao Y et al (2007) Increased invasive potential and up-regulation of MMP-2 in MDA-MB-231 breast cancer cells expressing the beta3 integrin subunit. Int J Oncol 30:325\u2013332","journal-title":"Int J Oncol"},{"key":"526_CR5","first-page":"18","volume":"35","author":"B Bian","year":"2003","unstructured":"Bian B, Ma C, You J, Ning J, Fang W, Zheng J (2003) The effects of TMSG-1 gene transfection on metastatic phenotype of pg cancer cells. Beijing Da Xue Xue Bao 35:18\u201322","journal-title":"Beijing Da Xue Xue Bao"},{"issue":"4","key":"526_CR6","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1677\/erc.1.01083","volume":"12","author":"SE Bojesen","year":"2005","unstructured":"Bojesen SE, Kjaer SK, H\u00f8gdall EV et al (2005) Increased risk of ovarian cancer in integrin beta3 Leu33Pro homozygotes. Endocr Relat Cancer 12(4):945\u2013952. doi: 10.1677\/erc.1.01083","journal-title":"Endocr Relat Cancer"},{"key":"526_CR7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/gyno.2000.5805","volume":"78","author":"JL Brun","year":"2000","unstructured":"Brun JL, Feyler A, Ch\u00eane G, Saurel J, Brun G, Hock\u00e9 C (2000) Long-term results and prognostic factors in patients with epithelial ovarian cancer. Gynecol Oncol 78:21\u201327. doi: 10.1006\/gyno.2000.5805","journal-title":"Gynecol Oncol"},{"key":"526_CR8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1089\/10430340150504019","volume":"12","author":"A Br\u00fcning","year":"2001","unstructured":"Br\u00fcning A, K\u00f6hler T, Quist S, Wang-Gohrke S, Moebus VJ, Kreienberg R et al (2001) Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphavbeta3. Hum Gene Ther 12:391\u2013399. doi: 10.1089\/10430340150504019","journal-title":"Hum Gene Ther"},{"key":"526_CR9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/(SICI)1097-0215(19990118)80:2<285::AID-IJC19>3.0.CO;2-L","volume":"80","author":"F Carreiras","year":"1999","unstructured":"Carreiras F, Rigot Y, Cruet S et al (1999) Migration properties of the human ovarian adenocarcinoma cell line IGROV1: importance of alpha (v) beta3 integrins and vitronectin. Int J Cancer 80:285\u2013294. doi :10.1002\/(SICI)1097-0215(19990118)80:2<285::AID-IJC19>3.0.CO;2-L","journal-title":"Int J Cancer"},{"key":"526_CR10","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/sj.onc.1206347","volume":"22","author":"S Cruet-Hennequart","year":"2003","unstructured":"Cruet-Hennequart S, Maubant S, Luis J, Gauduchon P, Staedel C, Dedhar S (2003) Alpha(v) integrins regulate cell proliferation through integrin-linked kinase (ILK) in ovarian cancer cells. Oncogene 22:1688\u20131702. doi: 10.1038\/sj.onc.1206347","journal-title":"Oncogene"},{"key":"526_CR11","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jocn.2007.06.019","volume":"14","author":"GM D\u2019Abaco","year":"2007","unstructured":"D\u2019Abaco GM, Kaye AH (2007) Integrins: molecular determinants of glioma invasion. J Clin Neurosci 14:1041\u20131048. doi: 10.1016\/j.jocn.2007.06.019","journal-title":"J Clin Neurosci"},{"key":"526_CR12","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.887927","volume":"197","author":"IJ Fidler","year":"1977","unstructured":"Fidler IJ, Kripke ML (1977) Metastasis results from preexisting variant cells within a malignant tumor. Science 197:893\u2013895. doi: 10.1126\/science.887927","journal-title":"Science"},{"key":"526_CR13","first-page":"6130","volume":"50","author":"IJ Fidler","year":"1990","unstructured":"Fidler IJ (1990) Critical factors in the biology of human cancer metastasis: twenty-eighth G H. A. Clowes Memorial Award Lecture. Cancer Res 50:6130\u20136138","journal-title":"Cancer Res"},{"key":"526_CR14","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/35099066","volume":"2","author":"B Geiger","year":"2001","unstructured":"Geiger B, Bershadsky A, Pankov R, Yamada KM (2001) Transmembrane crosstalk between the extracellular matrix\u2013cytoskeleton crosstalk. Nat Rev Mol Cell Biol 2:793\u2013805. doi: 10.1038\/35099066","journal-title":"Nat Rev Mol Cell Biol"},{"key":"526_CR15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/mpa.0b013e31811f4526","volume":"35","author":"JJ Grzesiak","year":"2007","unstructured":"Grzesiak JJ, Ho JC, Ar Moossa, Bouvet M (2007) The integrin\u2013extracellular matrix axis in pancreatic cancer. Pancreas 35:293\u2013301","journal-title":"Pancreas"},{"key":"526_CR16","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1515\/BC.2003.120","volume":"384","author":"S Hapke","year":"2003","unstructured":"Hapke S, Kessler H, Luber B et al (2003) Ovarian cancer cell proliferation and motility is induced by engagement of integrin alpha(v)beta3\/Vitronectin interaction. Biol Chem 384:1073\u20131083. doi: 10.1515\/BC.2003.120","journal-title":"Biol Chem"},{"key":"526_CR17","first-page":"463","volume":"62","author":"A Horiuchi","year":"2004","unstructured":"Horiuchi A, Konishi I (2004) Mechanism of ovarian cancer metastasis: changes in E-cadherin expression. Nippon Rinsho 62:463\u2013466","journal-title":"Nippon Rinsho"},{"key":"526_CR18","first-page":"513","volume":"23","author":"F Hata","year":"2004","unstructured":"Hata F, Nishimori H, Yasoshima T, Tanaka H, Ohno K, Yanai Y et al (2004) Profiling analysis of differential gene expression between hematogenous and peritoneal metastatic sublines of human pancreatic cancer using a DNA chip. J Exp Clin Cancer Res 23:513\u2013520","journal-title":"J Exp Clin Cancer Res"},{"key":"526_CR19","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/jmg.2006.047498","volume":"44","author":"A Jakubowska","year":"2007","unstructured":"Jakubowska A, Gronwald J, Menkiszak J et al (2007) Integrin beta3 Leu33Pro polymorphism increases BRCA1-associated ovarian cancer risk. J Med Genet 44:408\u2013411. doi: 10.1136\/jmg.2006.047498","journal-title":"J Med Genet"},{"key":"526_CR20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","volume":"57","author":"A Jemal","year":"2007","unstructured":"Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43\u201366","journal-title":"CA Cancer J Clin"},{"key":"526_CR21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1464-410X.2006.06196.x","volume":"98","author":"JP Kallio","year":"2006","unstructured":"Kallio JP, Mikkelsson J, Tammela TL, Karhunen PJ, Kellokumpu-Lehtinen P (2006) Genetic variation in platelet integrin alphabeta (GPIIb\/IIIa) and the metastatic potential of renal cell carcinoma. BJU Int 98:201\u2013204. doi: 10.1111\/j.1464-410X.2006.06196.x","journal-title":"BJU Int"},{"key":"526_CR22","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1158\/0008-5472.CAN-03-3354","volume":"64","author":"M Kanamori","year":"2004","unstructured":"Kanamori M, Vanden Berg SR, Bergers G, Berger MS, Pieper RO (2004) Integrin beta3 overexpression suppresses tumor growth in a human model of gliomagenesis: implications for the role of beta3 overexpression in glioblastoma multiforme. Cancer Res 64:2751\u20132758. doi: 10.1158\/0008-5472.CAN-03-3354","journal-title":"Cancer Res"},{"key":"526_CR23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-065X.2007.00532.x","volume":"218","author":"A Kasirer-Friede","year":"2007","unstructured":"Kasirer-Friede A, Kahn ML, Shattil SJ (2007) Platelet integrins and immunoreceptors. Immunol Rev 218:247\u2013264. doi: 10.1111\/j.1600-065X.2007.00532.x","journal-title":"Immunol Rev"},{"key":"526_CR24","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1091\/mbc.12.7.1983","volume":"12","author":"SH Kee","year":"2001","unstructured":"Kee SH, Steinert PM (2001) Microtubule disruption in keratinocytes induces cell\u2013cell adhesion through activation of endogenous E-cadherin. Mol Biol Cell 12:1983\u20131993","journal-title":"Mol Biol Cell"},{"key":"526_CR25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1083\/jcb.130.1.67","volume":"130","author":"KA Knudsen","year":"1995","unstructured":"Knudsen KA, Soler AP, Johnson KR, Wheelock MJ (1995) Interaction of alpha-actinin with the cadherin\/catenin cell\u2013cell adhesion complex via alpha-catenin. J Cell Biol 130:67\u201377. doi: 10.1083\/jcb.130.1.67","journal-title":"J Cell Biol"},{"key":"526_CR26","first-page":"21","volume":"21","author":"C Le Tourneau","year":"2007","unstructured":"Le Tourneau C, Faivre S, Raymond E (2007) The role of integrins in colorectal cancer. Oncology 21:21\u201324 Williston Park","journal-title":"Oncology"},{"key":"526_CR27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrm1789","volume":"7","author":"KR Legate","year":"2006","unstructured":"Legate KR, Monta\u00f1ez E, Kudlacek O, F\u00e4ssler R (2006) ILK, PINCH and parvin: the tIPP of integrin signalling. Nat Rev Mol Cell Biol 7:20\u201331. doi: 10.1038\/nrm1789","journal-title":"Nat Rev Mol Cell Biol"},{"key":"526_CR28","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1242\/jcs.107.12.3615","volume":"107","author":"JE Lewis","year":"1994","unstructured":"Lewis JE, Jensen PJ, Johnson KR, Wheelock MJ (1994) E-cadherin mediates adherens junction organization through protein kinase C. J Cell Sci 107:3615\u20133621","journal-title":"J Cell Sci"},{"key":"526_CR29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00432-002-0396-4","volume":"129","author":"Y Li","year":"2003","unstructured":"Li Y, Tang Y, Ye L, Liu B, Liu K, Chen J et al (2003) Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. J Cancer Res Clin Oncol 129:43\u201351. doi: 10.1007\/s00432-003-0493-z","journal-title":"J Cancer Res Clin Oncol"},{"key":"526_CR30","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3748\/wjg.14.421","volume":"14","author":"SG Li","year":"2008","unstructured":"Li SG, Ye ZY, Zhao ZS, Tao HQ, Wang YY, Niu CY (2008) Correlation of integrin beta3 mRNA and vascular endothelial growth factor protein expression profiles with the clinicopathological features and prognosis of gastric carcinoma. World J Gastroenterol 14:421\u2013427. doi: 10.3748\/wjg.14.421","journal-title":"World J Gastroenterol"},{"key":"526_CR31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0046-8177(97)90033-2","volume":"28","author":"H Liapis","year":"1997","unstructured":"Liapis H, Adler LM, Wick MR, Rader JS (1997) Expression of alpha(v)beta3 integrin is less frequent in ovarian epithelial tumors of low malignant potential in contrast to ovarian carcinomas. Hum Pathol 28:443\u2013449. doi: 10.1016\/S0046-8177(97)90033-2","journal-title":"Hum Pathol"},{"key":"526_CR32","first-page":"35","volume":"114","author":"Y Liu","year":"2001","unstructured":"Liu Y, Zheng J, Fang W, You J, Wang J, Cui X et al (2001) Identification of metastasis-associated gene G3BP by differential display in human cancer cell sublines with different metastatic potentials G3BP as highly expressed in non-metastatic. Chin Med J 114:35\u201338","journal-title":"Chin Med J"},{"key":"526_CR33","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ceb.2006.08.011","volume":"18","author":"SK Mitra","year":"2006","unstructured":"Mitra SK, Schlaepfer DD (2006) Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol 18:516\u2013523. doi: 10.1016\/j.ceb.2006.08.011","journal-title":"Curr Opin Cell Biol"},{"key":"526_CR34","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1023\/A:1027355610603","volume":"20","author":"T Nakano","year":"2003","unstructured":"Nakano T, Tani M, Ishibashi Y, Kimura K, Park YB et al (2003) Biological properties and gene expression associated with metastatic potential of human osteosarcoma. Clin Exp Metastasis 20:665\u2013674. doi: 10.1023\/A:1027355610603","journal-title":"Clin Exp Metastasis"},{"key":"526_CR35","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1600-0560.2007.00730.x","volume":"34","author":"DS Neto","year":"2007","unstructured":"Neto DS, Pantale\u00e3o L, de S\u00e1 BC, Landmam G (2007) Alpha-v-beta3 integrin expression in melanocytic nevi and cutaneous melanoma. J Cutan Pathol 34:851\u2013856. doi: 10.1111\/j.1600-0560.2007.00730.x","journal-title":"J Cutan Pathol"},{"key":"526_CR36","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1006\/scbi.2000.0337","volume":"10","author":"LV Parise","year":"2000","unstructured":"Parise LV, Lee J, Juliano RL (2000) New aspects of integrin signaling in cancer. Semin Cancer Biol 10:407\u2013414. doi: 10.1006\/scbi.2000.0337","journal-title":"Semin Cancer Biol"},{"key":"526_CR37","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74\u2013108","journal-title":"CA Cancer J Clin"},{"key":"526_CR38","first-page":"5808","volume":"52","author":"R Radinsky","year":"1992","unstructured":"Radinsky R, Weisberg HZ, Staroselsky AN, Fidler IJ (1992) Expression level of the nm23 gene in clonal populations of metastatic murine and human neoplasms. Cancer Res 52:5808\u20135814","journal-title":"Cancer Res"},{"key":"526_CR39","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2174\/138161208783413284","volume":"14","author":"JH Robertson","year":"2008","unstructured":"Robertson JH, Am Iga, Sales KM, Winslet MC, Seifalian AM (2008) Integrins: a method of early intervention in the treatment of colorectal liver metastases. Curr Pharm Des 14:296\u2013305. doi: 10.2174\/138161208783413284","journal-title":"Curr Pharm Des"},{"key":"526_CR40","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1034\/j.1600-0463.2002.100410.x","volume":"110","author":"T Sato","year":"2002","unstructured":"Sato T, Miwa A (2002) Ets-1 and integrin beta3 for lung metastasis from colorectal cancer. APMIS 110:347\u2013353. doi: 10.1034\/j.1600-0463.2002.100410.x","journal-title":"APMIS"},{"key":"526_CR41","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0002-9440(10)63370-6","volume":"165","author":"AK Sood","year":"2004","unstructured":"Sood AK, Coffin JE, Schneider GB, Fletcher MS, DeYoung BR et al (2004) Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion. Am J Pathol 165:1087\u20131095","journal-title":"Am J Pathol"},{"key":"526_CR42","first-page":"143","volume":"50","author":"K Switala-Jelen","year":"2004","unstructured":"Switala-Jelen K, Dabrowska K, Opolski A, Lipinska L, Nowaczyk M, Gorski A (2004) The biological functions of beta3 integrins. Folia Biol (Praha) 50:143\u2013152","journal-title":"Folia Biol (Praha)"},{"key":"526_CR43","first-page":"307","volume":"22","author":"H Tanaka","year":"2003","unstructured":"Tanaka H, Hata F, Nishimori H, Honmou O, Yasoshima T, Nomura H et al (2003) Differential gene expression screening between parental and highly metastatic pancreatic cancer variants using a DNA microarray. J Exp Clin Cancer Res 22:307\u2013313","journal-title":"J Exp Clin Cancer Res"},{"key":"526_CR44","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S1471-4892(02)00175-3","volume":"2","author":"GC Tucker","year":"2002","unstructured":"Tucker GC (2002) Inhibitors of integrins. Curr Opin Pharmacol 2:394\u2013402. doi: 10.1016\/S1471-4892(02)00175-3","journal-title":"Curr Opin Pharmacol"},{"key":"526_CR45","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/jcp.2005.029876","volume":"59","author":"KA Voutilainen","year":"2006","unstructured":"Voutilainen KA, Anttila MA, Sillanp\u00e4\u00e4 SM, Ropponen KM, Saarikoski SV, Juhola MT et al (2006) Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer. J Clin Pathol 59:460\u2013467. doi: 10.1136\/jcp.2005.029876","journal-title":"J Clin Pathol"},{"key":"526_CR46","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.4161\/cbt.5.10.3241","volume":"5","author":"K Watson-Hurst","year":"2006","unstructured":"Watson-Hurst K, Becker D (2006) The role of N-cadherin, MCAM and beta3 integrin in melanoma progression, proliferation, migration and invasion. Cancer Biol Ther 5:1375\u20131382","journal-title":"Cancer Biol Ther"},{"key":"526_CR47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1432-0436.2007.00193.x","volume":"76","author":"C Wu","year":"2008","unstructured":"Wu C, Cipollone J, Maines-Bandiera S, Tan C, Karsan A, Auersperg N et al (2008) The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression. Differentiation 76:193\u2013205. doi: 10.1111\/j.1432-0436.2007.00193.x","journal-title":"Differentiation"},{"key":"526_CR48","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3727\/000000006783981035","volume":"16","author":"Q Zhang","year":"2006","unstructured":"Zhang Q, Furukawa K, Chen HH, Fujinawa R, Kozutsumi Y et al (2006) Down-regulation of caveolin-1 in mouse Lewis lung cancer P29 is a causal factor for the malignant properties in a high-metastatic subline. Oncol Rep 16:289\u2013294","journal-title":"Oncol Rep"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-008-0526-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-008-0526-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-008-0526-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T13:42:09Z","timestamp":1632836529000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-008-0526-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,23]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["526"],"URL":"https:\/\/doi.org\/10.1007\/s00432-008-0526-8","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,23]]}}}